Universal Health Services, Inc.

UHS

HealthcareLarge CapUS Equities · NYSE / NASDAQ

AI Agents

Company Profile

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

Valuation

Market Cap$8.6B

Current Price$146.47as of Jun 23, 2026

P/E Ratio5.80

P/B Ratio1.19

EV / EBITDA4.98

EV / Sales0.79

Profitability

Operating Margin11.5%

Net Profit Margin8.6%

EBITDA Margin15.8%

Returns

ROE20.5%

ROCE17.7%

ROIC %-

ROA9.6%

Solvency

Current Ratio1.05

Debt / Equity0.71

Debt / Assets0.33

CFO / Net Profit1.25

Price History▼ 15.59% over 1Y

Technical Chart

Historical Performance Charts

5-year financial trends. Figures in USD millions.

Revenue vs Net Profit (5Y)

Free Cash Flow vs Operating Cash Flow (5Y)

Operating Margin % (5Y)

Growth Summary

Latest fiscal year: 2025

Revenue$17.4B▲ 9.7%

EBITDA$2.7B▲ 21.1%

Net Profit$1.5B▲ 30.4%

Cash from Ops (CFO)$1.9B▼ 9.8%

Free Cash Flow (FCF)$825M▼ 26.6%

Revenue CAGR 3Y9.0%

Revenue CAGR 5Y-

Net Profit CAGR 3Y30.1%

Net Profit CAGR 5Y-

Historical Growth

Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)

Year	Revenue	EBITDA	Net Profit	FCF	ROE	Rev Growth 1Y	NP Growth 1Y
2025	$17.4B	$2.7B	$1.5B	$825M	20.5%	9.7%	30.4%
2024	$15.8B	$2.3B	$1.1B	$1.1B	17.1%	10.8%	59.1%
2023	$14.3B	$1.7B	$718M	$525M	11.7%	6.6%	6.2%
2022	$13.4B	$1.6B	$676M	$262M	11.4%	-	-
2021

Financial Statements

Income statement, balance sheet, and cash flow as reported

Consolidated Figures in USD Millions.

Metric	2021	2022	2023	2024	2025
Total Revenue	-	13,399.37	14,281.98	15,827.94	17,364.83
Operating Revenue	-	13,399.37	14,281.98	15,827.94	17,364.83
Cost Of Revenue	-	1,474.34	1,532.83	1,587.79	1,659.01
Gross Profit	-	11,925.03	12,749.15	14,240.15	15,705.82
Operating Expense	-	10,921.48	11,573.77	12,558.34	13,711.80
Selling General And Administration	-	6,893.88	7,248.51	7,665.12	8,232.82
Total Expenses	-	12,395.82	13,106.60	14,146.12	15,370.81
Operating Income	-	1,003.56	1,175.38	1,681.81	1,994.02
Total Operating Income As Reported	-	1,003.56	1,175.38	1,681.81	1,994.02
EBITDA	-	1,575.01	1,715.14	2,265.28	2,743.14
Normalized EBITDA	-	1,575.01	1,715.14	2,265.28	2,743.14
EBIT	-	993.15	1,147.10	1,680.45	2,124.40
Interest Income	-	0.38	0.57	1.42	1.19
Interest Expense	-	126.89	206.67	182.51	152.26
Net Interest Income	-	-126.89	-206.67	-186.11	-156.07
Other Non Operating Income Expenses	-	-10.41	-28.28	2.23	134.19
Other Income Expense	-	-10.41	-28.28	2.23	134.19
Interest Income Non Operating	-	0.38	0.57	1.42	1.19
Interest Expense Non Operating	-	126.89	206.67	182.51	152.26
Net Non Operating Interest Income Expense	-	-126.89	-206.67	-186.11	-156.07
Pretax Income	-	866.26	940.43	1,497.94	1,972.14
Tax Provision	-	209.28	221.12	334.83	460.96
Tax Rate For Calcs	-	0	0	0	0
Tax Effect Of Unusual Items	-	0	0	0	0
Net Income Continuous Operations	-	656.98	719.31	1,163.11	1,511.18
Net Income From Continuing And Discontinued Operation	-	675.61	717.80	1,142.10	1,488.80
Net Income From Continuing Operation Net Minority Interest	-	675.61	717.80	1,142.10	1,488.80
Net Income	-	675.61	717.80	1,142.10	1,488.80
Net Income Common Stockholders	-	674.86	717.49	1,142.05	1,488.80
Net Income Including Noncontrolling Interests	-	656.98	719.31	1,163.11	1,511.18
Normalized Income	-	675.61	717.80	1,142.10	1,488.80
Diluted NI Availto Com Stockholders	-	674.86	717.49	1,142.05	1,488.80
Basic Average Shares	-	73.12	69.32	66.55	63.58
Diluted Average Shares	-	73.83	70.12	67.90	64.46
Reconciled Depreciation	-	581.86	568.04	584.83	618.74
Reconciled Cost Of Revenue	-	1,474.34	1,532.83	1,587.79	1,659.01
Minority Interests	-	18.63	-1.51	-21.01	-22.39
Depreciation Amortization Depletion Income Statement	-	581.86	568.04	584.83	618.74
Depreciation And Amortization In Income Statement	-	581.86	568.04	584.83	618.74
General And Administrative Expense	-	6,893.88	7,248.51	7,665.12	8,232.82
Salaries And Wages	-	6,762.26	7,107.48	7,518.69	8,084.58
Rent Expense Supplemental	-	131.63	141.03	146.43	148.23
Total Other Finance Cost	-	4.90	5.04	5.02	5
Other Operating Expenses	-	3,445.73	3,757.22	4,308.38	4,860.25
Rent And Landing Fees	-	131.63	141.03	146.43	148.23
Otherunder Preferred Stock Dividend	-	0.75	0.31	0.05	0

Peer Comparison

Healthcare sector peers, ranked by market cap

Company	Ticker	Market Cap	P/E	P/B	ROE	EV/EBITDA
Universal Health Services, Inc.this co.	UHS	$8.6B	5.80↓ discount	1.19	20.5%	4.98
Incyte Corporation	INCY	$20.2B	15.72	3.91	24.9%	9.75
Viatris Inc.	VTRS	$18.5B	-	1.26	-23.9%	-
Zimmer Biomet Holdings, Inc.	ZBH	$16.8B	23.79	1.32	5.6%	10.69
Solventum Corporation	SOLV	$14.3B

Learn while you research

Hand-picked academy chapters to deepen your understanding of Universal Health Services, Inc. and the metrics that matter.

01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read 02 Value Investing

Loading…

Year

Revenue

EBITDA

Net Profit

FCF

ROE

Rev Growth 1Y

NP Growth 1Y

2025

$17.4B

$2.7B

$1.5B

$825M

20.5%

9.7%

30.4%

2024

$15.8B

$2.3B

$1.1B

17.1%

10.8%

59.1%

2023

$14.3B

$1.7B

$718M

$525M

11.7%

6.6%

6.2%

2022

$13.4B

$1.6B

$676M

$262M

11.4%

2021

Metric

2021

2022

2023

2024

2025

Total Revenue

13,399.37

14,281.98

15,827.94

17,364.83

Operating Revenue

13,399.37

14,281.98

15,827.94

17,364.83

Cost Of Revenue

1,474.34

1,532.83

1,587.79

1,659.01

Gross Profit

11,925.03

12,749.15

14,240.15

15,705.82

Operating Expense

10,921.48

11,573.77

12,558.34

13,711.80

Selling General And Administration

6,893.88

7,248.51

7,665.12

8,232.82

Total Expenses

12,395.82

13,106.60

14,146.12

15,370.81

Operating Income

1,003.56

1,175.38

1,681.81

1,994.02

Total Operating Income As Reported

1,003.56

1,175.38

1,681.81

1,994.02

EBITDA

1,575.01

1,715.14

2,265.28

2,743.14

Normalized EBITDA

1,575.01

1,715.14

2,265.28

2,743.14

EBIT

993.15

1,147.10

1,680.45

2,124.40

Interest Income

0.38

0.57

1.42

1.19

Interest Expense

126.89

206.67

182.51

152.26

Net Interest Income

-126.89

-206.67

-186.11

-156.07

Other Non Operating Income Expenses

-10.41

-28.28

2.23

134.19

Other Income Expense

-10.41

-28.28

2.23

134.19

Interest Income Non Operating

0.38

0.57

1.42

1.19

Interest Expense Non Operating

126.89

206.67

182.51

152.26

Net Non Operating Interest Income Expense

-126.89

-206.67

-186.11

-156.07

Pretax Income

866.26

940.43

1,497.94

1,972.14

Tax Provision

209.28

221.12

334.83

460.96

Tax Rate For Calcs

Tax Effect Of Unusual Items

Net Income Continuous Operations

656.98

719.31

1,163.11

1,511.18

Net Income From Continuing And Discontinued Operation

675.61

717.80

1,142.10

1,488.80

Net Income From Continuing Operation Net Minority Interest

675.61

717.80

1,142.10

1,488.80

Net Income

675.61

717.80

1,142.10

1,488.80

Net Income Common Stockholders

674.86

717.49

1,142.05

1,488.80

Net Income Including Noncontrolling Interests

656.98

719.31

1,163.11

1,511.18

Normalized Income

675.61

717.80

1,142.10

1,488.80

Diluted NI Availto Com Stockholders

674.86

717.49

1,142.05

1,488.80

Basic Average Shares

73.12

69.32

66.55

63.58

Diluted Average Shares

73.83

70.12

67.90

64.46

Reconciled Depreciation

581.86

568.04

584.83

618.74

Reconciled Cost Of Revenue

1,474.34

1,532.83

1,587.79

1,659.01

Minority Interests

18.63

-1.51

-21.01

-22.39

Depreciation Amortization Depletion Income Statement

581.86

568.04

584.83

618.74

Depreciation And Amortization In Income Statement

581.86

568.04

584.83

618.74

General And Administrative Expense

6,893.88

7,248.51

7,665.12

8,232.82

Salaries And Wages

6,762.26

7,107.48

7,518.69

8,084.58

Rent Expense Supplemental

131.63

141.03

146.43

148.23

Total Other Finance Cost

4.90

5.04

5.02

Other Operating Expenses

3,445.73

3,757.22

4,308.38

4,860.25

Rent And Landing Fees

131.63

141.03

146.43

148.23

Otherunder Preferred Stock Dividend

0.75

0.31

0.05

Company

Ticker

Market Cap

P/E

P/B

ROE

EV/EBITDA

Universal Health Services, Inc.this co.

UHS

$8.6B

5.80↓ discount

1.19

20.5%

4.98

Incyte Corporation

INCY

$20.2B

15.72

3.91

24.9%

9.75

Viatris Inc.

VTRS

$18.5B

1.26

-23.9%

Zimmer Biomet Holdings, Inc.

ZBH

$16.8B

23.79

1.32

5.6%

10.69

Solventum Corporation

SOLV

$14.3B

Universal Health Services, Inc.

Valuation

Profitability

Returns

Solvency

Historical Performance Charts

Revenue vs Net Profit (5Y)

Free Cash Flow vs Operating Cash Flow (5Y)

Operating Margin % (5Y)

Growth Summary

Historical Growth

Financial Statements

Peer Comparison

Universal Health Services, Inc.

Valuation

Profitability

Returns

Solvency

Historical Performance Charts

Revenue vs Net Profit (5Y)

Free Cash Flow vs Operating Cash Flow (5Y)

Operating Margin % (5Y)

Growth Summary

Historical Growth

Financial Statements

Peer Comparison

Key concepts to brush up on